[go: up one dir, main page]

DE60002855D1 - Haloalkoxy-imidazonaphthyridine - Google Patents

Haloalkoxy-imidazonaphthyridine

Info

Publication number
DE60002855D1
DE60002855D1 DE60002855T DE60002855T DE60002855D1 DE 60002855 D1 DE60002855 D1 DE 60002855D1 DE 60002855 T DE60002855 T DE 60002855T DE 60002855 T DE60002855 T DE 60002855T DE 60002855 D1 DE60002855 D1 DE 60002855D1
Authority
DE
Germany
Prior art keywords
imidazonaphthyridine
haloalkoxy
compounds
useful
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60002855T
Other languages
English (en)
Other versions
DE60002855T2 (de
Inventor
Gerhard Grundler
Wolfgang-Alexander Simon
Stefan Postius
Wolfgang Kromer
Joerg Senn-Bilfinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of DE60002855D1 publication Critical patent/DE60002855D1/de
Application granted granted Critical
Publication of DE60002855T2 publication Critical patent/DE60002855T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60002855T 1999-04-17 2000-04-14 Haloalkoxy-imidazonaphthyridine Expired - Fee Related DE60002855T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99107688 1999-04-17
EP99107688 1999-04-17
PCT/EP2000/003388 WO2000063211A1 (en) 1999-04-17 2000-04-14 Haloalkoxy imidazonaphthyridines

Publications (2)

Publication Number Publication Date
DE60002855D1 true DE60002855D1 (de) 2003-06-26
DE60002855T2 DE60002855T2 (de) 2004-05-06

Family

ID=8237986

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60002855T Expired - Fee Related DE60002855T2 (de) 1999-04-17 2000-04-14 Haloalkoxy-imidazonaphthyridine

Country Status (12)

Country Link
US (1) US6503923B1 (de)
EP (1) EP1173439B1 (de)
JP (1) JP2002542248A (de)
AT (1) ATE240956T1 (de)
AU (1) AU3966600A (de)
CA (1) CA2370231A1 (de)
DE (1) DE60002855T2 (de)
DK (1) DK1173439T3 (de)
ES (1) ES2199810T3 (de)
PT (1) PT1173439E (de)
SI (1) SI1173439T1 (de)
WO (1) WO2000063211A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2426616A1 (en) 2000-10-25 2002-05-02 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002069968A1 (en) * 2001-03-08 2002-09-12 Astrazeneca Ab New use
DE60214004T2 (de) 2001-08-02 2007-02-15 Altana Pharma Ag Tricyclische epoxide
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
JP2005504048A (ja) * 2001-08-03 2005-02-10 アルタナ　ファルマ　アクチエンゲゼルシャフト 胃腸障害治療用のアルカリ置換されたイミダゾピリジン
KR20040081204A (ko) 2002-02-15 2004-09-20 알타나 파마 아게 트리시클릭 ｎ-아실 화합물
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
KR20050086584A (ko) 2002-11-19 2005-08-30 알타나 파마 아게 8-치환 이미다조피리딘
CA2515676A1 (en) * 2003-02-17 2004-08-26 Altana Pharma Ag Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
AU2004220357B2 (en) 2003-03-10 2010-09-30 Astrazeneca Ab Novel process for the preparation of roflumilast
AU2004243444A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
WO2005041961A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
AR046893A1 (es) * 2003-12-16 2005-12-28 Altana Pharma Ag Bencimidazoles triciclicos
EP1697358A1 (de) 2003-12-19 2006-09-06 Altana Pharma AG Zwischenprodukte für die darstellung tricyclischer dihydropyranoimidazopyridinderivate
AR047605A1 (es) * 2004-02-17 2006-01-25 Altana Pharma Ag Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos.
US7931659B2 (en) * 2004-09-10 2011-04-26 Penumbra, Inc. System and method for treating ischemic stroke
AU2005291284A1 (en) * 2004-10-01 2006-04-13 Altana Pharma Ag Substituted tricyclic benzimidazoles
EP1861074B1 (de) * 2005-03-16 2013-04-24 Takeda GmbH Geschmacksmaskierte dosierform von roflumilast

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EP0971922B1 (de) * 1997-03-24 2004-04-28 ALTANA Pharma AG Tetrahydropyridoverbindungen
RS50145B (sr) 1998-09-23 2009-03-25 Altana Pharma Ag., Tetrahidropiridoetri

Also Published As

Publication number Publication date
JP2002542248A (ja) 2002-12-10
AU3966600A (en) 2000-11-02
SI1173439T1 (en) 2003-10-31
EP1173439A1 (de) 2002-01-23
DK1173439T3 (da) 2003-09-08
CA2370231A1 (en) 2000-10-26
ES2199810T3 (es) 2004-03-01
WO2000063211A1 (en) 2000-10-26
ATE240956T1 (de) 2003-06-15
EP1173439B1 (de) 2003-05-21
DE60002855T2 (de) 2004-05-06
PT1173439E (pt) 2003-10-31
US6503923B1 (en) 2003-01-07

Similar Documents

Publication Publication Date Title
DE60002855D1 (de) Haloalkoxy-imidazonaphthyridine
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
ES2170252T3 (es) Tetrahidroimidazopiridoindoldionas como inhibidores de cgmp especifico pde.
ATE302775T1 (de) Carbolinderivate
AR023777A1 (es) Nuevos compuestos
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE346067T1 (de) Carbolinderivate
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
TR200401316T4 (tr) Proliferatif hastalıkları tedavi etmek için yöntemler ve bileşikler
DE60121345D1 (de) Alkylierte imidazopyridinderivate
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
DE60112960D1 (de) Kondensierte pyridoindolderivate
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
MXPA04005129A (es) Uso de diamina de acido piridin-2,4-dicarboxilico y de diaminas de acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de la colagenasa.
ATE259813T1 (de) Triazolopyrimidinderivate
DE60007120D1 (de) Isophosphoramide-senfgasanalogen und deren verwendung
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
MY135375A (en) Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
MXPA03000887A (es) Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
SG171472A1 (en) Substituted aniline derivatives
NO20005548D0 (no) Mykobakterieinhibitorer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE

8339 Ceased/non-payment of the annual fee